IMD INTERNATIONAL MEDICAL DE (IMD.MI) Fundamental Analysis & Valuation

BIT:IMD • IT0005549255

Current stock price

1.35 EUR
-0.03 (-2.17%)
Last:

This IMD.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. IMD.MI Profitability Analysis

1.1 Basic Checks

  • IMD had positive earnings in the past year.
  • In the past year IMD had a positive cash flow from operations.
IMD.MI Yearly Net Income VS EBIT VS OCF VS FCFIMD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

  • The Return On Assets of IMD (4.04%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 6.09%, IMD is in line with its industry, outperforming 44.62% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.85%, IMD is doing worse than 61.54% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for IMD is above the industry average of 10.21%.
  • The 3 year average ROIC (12.28%) for IMD is well above the current ROIC(4.85%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.04%
ROE 6.09%
ROIC 4.85%
ROA(3y)7.1%
ROA(5y)N/A
ROE(3y)13.65%
ROE(5y)N/A
ROIC(3y)12.28%
ROIC(5y)N/A
IMD.MI Yearly ROA, ROE, ROICIMD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30

1.3 Margins

  • IMD has a Profit Margin (3.70%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of IMD has declined.
  • IMD's Operating Margin of 4.83% is on the low side compared to the rest of the industry. IMD is outperformed by 64.62% of its industry peers.
  • In the last couple of years the Operating Margin of IMD has declined.
  • With a Gross Margin value of 24.88%, IMD is not doing good in the industry: 89.23% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of IMD has declined.
Industry RankSector Rank
OM 4.83%
PM (TTM) 3.7%
GM 24.88%
OM growth 3Y-15.05%
OM growth 5YN/A
PM growth 3Y-13.98%
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5YN/A
IMD.MI Yearly Profit, Operating, Gross MarginsIMD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. IMD.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IMD is still creating some value.
  • The number of shares outstanding for IMD remains at a similar level compared to 1 year ago.
  • IMD has a better debt/assets ratio than last year.
IMD.MI Yearly Shares OutstandingIMD.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
IMD.MI Yearly Total Debt VS Total AssetsIMD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 3.90 indicates that IMD is not in any danger for bankruptcy at the moment.
  • IMD has a Altman-Z score of 3.90. This is in the better half of the industry: IMD outperforms 69.23% of its industry peers.
  • IMD has a debt to FCF ratio of 0.19. This is a very positive value and a sign of high solvency as it would only need 0.19 years to pay back of all of its debts.
  • The Debt to FCF ratio of IMD (0.19) is better than 93.85% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that IMD is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.01, IMD belongs to the top of the industry, outperforming 89.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.19
Altman-Z 3.9
ROIC/WACC0.61
WACC7.93%
IMD.MI Yearly LT Debt VS Equity VS FCFIMD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 3.53 indicates that IMD has no problem at all paying its short term obligations.
  • IMD has a better Current ratio (3.53) than 90.77% of its industry peers.
  • A Quick Ratio of 1.74 indicates that IMD should not have too much problems paying its short term obligations.
  • The Quick ratio of IMD (1.74) is better than 75.38% of its industry peers.
Industry RankSector Rank
Current Ratio 3.53
Quick Ratio 1.74
IMD.MI Yearly Current Assets VS Current LiabilitesIMD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. IMD.MI Growth Analysis

3.1 Past

  • IMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.43%.
  • IMD shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.97% yearly.
  • IMD shows a decrease in Revenue. In the last year, the revenue decreased by -5.61%.
  • IMD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.22% yearly.
EPS 1Y (TTM)-48.43%
EPS 3Y-17.97%
EPS 5YN/A
EPS Q2Q%-66.28%
Revenue 1Y (TTM)-5.61%
Revenue growth 3Y-5.22%
Revenue growth 5YN/A
Sales Q2Q%-15.36%

3.2 Future

  • Based on estimates for the next years, IMD will show a decrease in Earnings Per Share. The EPS will decrease by -6.27% on average per year.
  • IMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.81% yearly.
EPS Next Y-23.53%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
EPS Next 5YN/A
Revenue Next Year0.61%
Revenue Next 2Y1.52%
Revenue Next 3Y1.81%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMD.MI Yearly Revenue VS EstimatesIMD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
IMD.MI Yearly EPS VS EstimatesIMD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.05 0.1 0.15 0.2

More info and screens

Find the best growth stocksShow best growing peers

6

4. IMD.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.88, the valuation of IMD can be described as correct.
  • 89.23% of the companies in the same industry are more expensive than IMD, based on the Price/Earnings ratio.
  • IMD is valuated rather cheaply when we compare the Price/Earnings ratio to 26.78, which is the current average of the S&P500 Index.
  • IMD is valuated reasonably with a Price/Forward Earnings ratio of 9.55.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IMD indicates a rather cheap valuation: IMD is cheaper than 92.31% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of IMD to the average of the S&P500 Index (23.54), we can say IMD is valued rather cheaply.
Industry RankSector Rank
PE 16.88
Fwd PE 9.55
IMD.MI Price Earnings VS Forward Price EarningsIMD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IMD is valued cheaply inside the industry as 89.23% of the companies are valued more expensively.
  • IMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IMD is cheaper than 93.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.64
EV/EBITDA 7.7
IMD.MI Per share dataIMD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • IMD's earnings are expected to decrease with -6.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. IMD.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.41%, IMD is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.16, IMD pays a better dividend. On top of this IMD pays more dividend than 100.00% of the companies listed in the same industry.
  • IMD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 7.41%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 212.93% of the earnings are spent on dividend by IMD. This is not a sustainable payout ratio.
DP212.93%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
IMD.MI Yearly Income VS Free CF VS DividendIMD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 2M -2M 4M -4M 6M
IMD.MI Dividend Payout.IMD.MI Dividend Payout, showing the Payout Ratio.IMD.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IMD.MI Fundamentals: All Metrics, Ratios and Statistics

IMD INTERNATIONAL MEDICAL DE

BIT:IMD (2/18/2026, 7:00:00 PM)

1.35

-0.03 (-2.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.87%
Inst Owner ChangeN/A
Ins Owners75.51%
Ins Owner ChangeN/A
Market Cap23.83M
Revenue(TTM)36.29M
Net Income(TTM)1.34M
Analysts45.71
Price Target1.53 (13.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.41%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP212.93%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.88
Fwd PE 9.55
P/S 0.66
P/FCF 10.64
P/OCF 8.19
P/B 1.08
P/tB 1.15
EV/EBITDA 7.7
EPS(TTM)0.08
EY5.93%
EPS(NY)0.14
Fwd EY10.47%
FCF(TTM)0.13
FCFY9.4%
OCF(TTM)0.16
OCFY12.22%
SpS2.06
BVpS1.25
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.5
Profitability
Industry RankSector Rank
ROA 4.04%
ROE 6.09%
ROCE 7.08%
ROIC 4.85%
ROICexc 6.32%
ROICexgc 6.81%
OM 4.83%
PM (TTM) 3.7%
GM 24.88%
FCFM 6.17%
ROA(3y)7.1%
ROA(5y)N/A
ROE(3y)13.65%
ROE(5y)N/A
ROIC(3y)12.28%
ROIC(5y)N/A
ROICexc(3y)15.57%
ROICexc(5y)N/A
ROICexgc(3y)16.37%
ROICexgc(5y)N/A
ROCE(3y)17.89%
ROCE(5y)N/A
ROICexgc growth 3Y-23.19%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.4%
ROICexc growth 5YN/A
OM growth 3Y-15.05%
OM growth 5YN/A
PM growth 3Y-13.98%
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5YN/A
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.19
Debt/EBITDA 0.1
Cap/Depr 104.88%
Cap/Sales 1.85%
Interest Coverage 250
Cash Conversion 121.64%
Profit Quality 167.02%
Current Ratio 3.53
Quick Ratio 1.74
Altman-Z 3.9
F-Score6
WACC7.93%
ROIC/WACC0.61
Cap/Depr(3y)149.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.29%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.43%
EPS 3Y-17.97%
EPS 5YN/A
EPS Q2Q%-66.28%
EPS Next Y-23.53%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.61%
Revenue growth 3Y-5.22%
Revenue growth 5YN/A
Sales Q2Q%-15.36%
Revenue Next Year0.61%
Revenue Next 2Y1.52%
Revenue Next 3Y1.81%
Revenue Next 5YN/A
EBIT growth 1Y-52.97%
EBIT growth 3Y-19.48%
EBIT growth 5YN/A
EBIT Next Year-3.63%
EBIT Next 3Y-1.22%
EBIT Next 5YN/A
FCF growth 1Y354.49%
FCF growth 3Y32.27%
FCF growth 5YN/A
OCF growth 1Y712.77%
OCF growth 3Y35.57%
OCF growth 5YN/A

IMD INTERNATIONAL MEDICAL DE / IMD.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IMD INTERNATIONAL MEDICAL DE (IMD.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to IMD.MI.


Can you provide the valuation status for IMD INTERNATIONAL MEDICAL DE?

ChartMill assigns a valuation rating of 6 / 10 to IMD INTERNATIONAL MEDICAL DE (IMD.MI). This can be considered as Fairly Valued.


What is the profitability of IMD stock?

IMD INTERNATIONAL MEDICAL DE (IMD.MI) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for IMD stock?

The Price/Earnings (PE) ratio for IMD INTERNATIONAL MEDICAL DE (IMD.MI) is 16.88 and the Price/Book (PB) ratio is 1.08.


Is the dividend of IMD INTERNATIONAL MEDICAL DE sustainable?

The dividend rating of IMD INTERNATIONAL MEDICAL DE (IMD.MI) is 5 / 10 and the dividend payout ratio is 212.93%.